Offer - Urjas Oil for just ₹ 1 X
ADVAGRAF 1MG CAPSULE 10S is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of ADVAGRAF 1MG CAPSULE 10S safe for pregnant women?
Advagraf can have harmful effects in pregnant women. If you experience any discomfort after using Advagraf, then discontinue the use and take your doctor's advice.
Is the use of ADVAGRAF 1MG CAPSULE 10S safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Advagraf. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of ADVAGRAF 1MG CAPSULE 10S on the Kidneys?
There may be some adverse effects on kidney after taking Advagraf. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of ADVAGRAF 1MG CAPSULE 10S on the Liver?
Advagraf may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of ADVAGRAF 1MG CAPSULE 10S on the Heart?
Advagraf may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take ADVAGRAF 1MG CAPSULE 10S unless your doctor advises you to do so -
Is this ADVAGRAF 1MG CAPSULE 10S habit forming or addictive?
No, there is no any evidence that ADVAGRAF 1MG CAPSULE 10S is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking ADVAGRAF 1MG CAPSULE 10S as it does not make you drowsy.
Is it safe?
Yes, ADVAGRAF 1MG CAPSULE 10S is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
ADVAGRAF 1MG CAPSULE 10S is unable to treat or cure mental disorders.
Interaction between Food and ADVAGRAF 1MG CAPSULE 10S
Due to the absence of research, it is difficult to say how ADVAGRAF 1MG CAPSULE 10S and food will interact.
Interaction between Alcohol and ADVAGRAF 1MG CAPSULE 10S
Taking ADVAGRAF 1MG CAPSULE 10S with alcohol can have severely harmful effects on your health.
No, Advagraf is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take for this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before using this medication by himself or herself.
No, you cannot take the Advagraf with fluconazole, as it may change the effect of the Advagraf and cause some serious side effects, always consult your doctor before taking this drug combination.
No, you cannot take the Advagraf with Ibuprofen, as it may change the effect of the Advagraf and cause some serious side effects, always consult your doctor before taking this drug combination.
Take Advagraf as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Advagraf is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as headache, diarrhea, constipation, nausea, vomiting. If you experience any discomfort after taking this do inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167